However, SETDB1 deficiency arrests CRC cells in G1 phase to inhibit cell proliferation and CRC tumorigenesis by decreasing H3K9me3 enrichment at the promoter of p21 and then suppressing p21 expression (Fig. 4) [102]. Here, SETDB1 is linked to colorectal carcinoma.